STACEY ELWOOD: Open Payments
NPI 1346682234 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,549 in 119 payments from 14 companies in 2025. Trend: 2023 $341 · 2024 $2,836 · 2025 $2,549
Food & beverage: $2,414Education: $135
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $826 |
| ABBVIE INC. | 50 | $743 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $405 |
| Lilly USA, LLC | 2 | $114 |
| QOL Medical, LLC | 6 | $100 |
| Madrigal Pharmaceuticals | 2 | $83 |
| Ardelyx, Inc. | 4 | $73 |
| Gilead Sciences, Inc. | 2 | $44 |
| GENZYME CORPORATION | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
Products named: TREMFYA, RINVOQ, ENTYVIO, LINZESS, SKYRIZI, OMVOH, Sucraid, DUPIXENT.
Industry payments across IN — which companies pay providers there.
